Among these are the SET domain-containing 5 (Setd5) promoter (Fig. 5b)43, the Phosphoglucokinase (Pgk1) promoter (Fig. 5c)44, which are also from the PDGFB-driven tumor and normal comparison, displaying clear differences between the tumors. This evidence concerns the gene SETD5 and neoplasm.